Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Dalian Medical UniversityNo recent work listed

Yunlong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1852-9688; OpenAlex author ID A5101579071. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? Co-author DOI 10.3389/fonc.2022.828223↗
  2. Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis. Co-author DOI 10.1097/md.0000000000026342↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dan Chen · 2 shared papers, 2021–2022 · strength 0.25
  2. Chenqi Wang · 2 shared papers, 2021–2022 · strength 0.25
  3. Xiang 'Anthony' Chen · 2 shared papers, 2021–2022 · strength 0.25
  4. Jiangning Gu · 2 shared papers, 2021–2022 · strength 0.25
  5. Haifeng Luo · 2 shared papers, 2021–2022 · strength 0.25
  6. Lili Yang · 1 shared paper, 2022 · strength 0.13
  7. Guang Tan · 1 shared paper, 2022 · strength 0.13
  8. Jian Du · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.